CSIMarket
 


Beam Therapeutics Inc   (BEAM)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

BEAM's Net Income Growth by Quarter and Year

Beam Therapeutics Inc 's Net Income results by quarter and year




BEAM Net Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -95.46 -0.86 114.50
III Quarter September - -34.45 88.90 126.30
II Quarter June - -34.22 84.80 76.50
I Quarter March -201.56 -30.46 74.30 100.50
FY   -201.56 -194.59 247.14 417.80



BEAM Net Income first quarter 2021 Y/Y Growth Comment
Beam Therapeutics Inc in the first quarter recorded net loss of $ -201.56 millions.

According to the results reported in the first quarter, Beam Therapeutics Inc achieved the best Net Income growth in Biotechnology & Drugs industry. While Beam Therapeutics Inc ' s Net Income no change of % ranks overall at the positon no. in the first quarter.




BEAM Net Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - 44.75 %
III Quarter September - - -29.61 % 34.22 %
II Quarter June - - 10.85 % -81.48 %
I Quarter March - - -26.07 % -69.42 %
FY   - - -40.85 % -54.33 %

Financial Statements
Beam Therapeutics Inc 's first quarter 2021 Net Income $ -201.56 millions BEAM's Income Statement
Beam Therapeutics Inc 's first quarter 2020 Net Income $ -30.46 millions Quarterly BEAM's Income Statement
New: More BEAM's historic Net Income Growth >>


BEAM Net Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -9.34 %
III Quarter September - - 4.83 % 65.1 %
II Quarter June - - 14.13 % -23.88 %
I Quarter March - - -35.11 % 27.05 %
FY (Year on Year)   - - -40.85 % -54.33 %




Net Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Beam Therapeutics Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BEAM's I. Quarter Q/Q Net Income Comment
Recent accomplishment of -201.56 millions by Beam Therapeutics Inc look even less good considering the -95.46 millions in the previous quarter.

Within Biotechnology & Drugs industry Beam Therapeutics Inc achieved highest sequential Net Income growth. While Beam Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BEAM's I. Quarter Q/Q Net Income Comment
Current accomplishment of -201.56 millions by Beam Therapeutics Inc appear even less good compare to the -95.46 millions in the forth quarter.

Within Biotechnology & Drugs industry Beam Therapeutics Inc achieved highest sequential Net Income growth. While Beam Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Beam Therapeutics Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Net Income 12 Months Ending $ -365.69 $ -194.59 $ -99.98 $ 23.37 $ 142.39
Y / Y Net Income Growth (TTM) - - - -94.16 % -63.64 %
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - -83.59 % -42.39 %
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Beam Therapeutics Inc realized trailing twelve months net loss of $ -366 millions, in the Mar 31 2021, compare to Net Income of $ 142 millions a year ago.

Beam Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Beam Therapeutics Inc realized trailing twelve months net loss of $ -366 millions, in the Mar 31 2021, compare to Net Income of $ 142 millions a year ago.

Beam Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
BEAM's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for BEAM's Competitors
Net Income Growth for Beam Therapeutics Inc 's Suppliers
Net Income Growth for BEAM's Customers

You may also want to know
BEAM's Annual Growth Rates BEAM's Profitability Ratios BEAM's Asset Turnover Ratio BEAM's Dividend Growth
BEAM's Roe BEAM's Valuation Ratios BEAM's Financial Strength Ratios BEAM's Dividend Payout Ratio
BEAM's Roa BEAM's Inventory Turnover Ratio BEAM's Growth Rates BEAM's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2021
Hologic Inc543.72%$ 543.718 millions
Surmodics Inc 453.15%$ 453.146 millions
Bruker Corporation445.28%$ 445.283 millions
Integra Lifesciences Holdings Corp394.49%$ 394.488 millions
Apollo Medical Holdings Inc 384.03%$ 384.031 millions
Quest Diagnostics Inc362.26%$ 362.264 millions
Quidel Corporation342.59%$ 342.588 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RESN's Profile

Stock Price

RESN's Financials

Business Description

Fundamentals

Charts & Quotes

RESN's News

Suppliers

RESN's Competitors

Customers & Markets

Economic Indicators

RESN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071